Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Finding Study of Tapinarof Cream in Atopic Dermatitis
NCT02564055Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tapinarof in atopic dermatitis (AD), sponsored by GSK. Started Dec 2015; status: completed.
02
Drugs
tapinarof
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02564055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02564055.